Labverity
Facility profile

StemCyte, Inc.

Drug product manufacturing · Baldwin Park, CA

FDA recordFDA directory updated Jul 21, 2026Profile not yet claimed
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

Manufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 21, 2026

Latest matched inspection
No action indicated (NAI)

Jul 31, 2019 · No conditions warranted FDA action in this inspection.

Matched compliance actions
None in our records

No warning letter, injunction, or seizure matched.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched no action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Confirm the inspection scope and whether it covered the work you need.

Method and source details
View full inspection and compliance history4 inspection records

FDA inspection history

4 records, Feb 2010 – Jul 2019 · 2 NAI · 2 VAI · 0 OAI

DateClassProject areaCitationsFY
Jul 31, 2019NAIHuman Cellular, Tissue, and Gene Therapies2019
Mar 12, 2013VAIHuman Cellular, Tissue, and Gene TherapiesYes2013
Jul 28, 2011NAIHuman Cellular, Tissue, and Gene Therapies2011
Feb 11, 2010VAIHuman Cellular, Tissue, and Gene TherapiesYes2010

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

No warning letter, injunction, or seizure is matched in the current data set.

Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services